10 Pharmaceutical Stocks to Buy According to Lawrence Hawkins' Prosight Capital
In this article, we discuss 10 pharmaceutical stocks to buy according to Lawrence Hawkins' Prosight Capital.
Established in November 2008, Prosight Management is a Texas-based hedge fund manager founded by William Lawrence Hawkins. The firm focuses on capital appreciation for clients by primarily establishing long/short positions in publicly traded securities, particularly those of healthcare-related issuers.
William Lawrence Hawkins founded Prosight Management LP in 2008 and currently serves as its Managing Partner. He also holds the position of Director at Prosight Plus Fund LP. Previously, Mr. Hawkins held roles as Managing Director at Bonanza Capital Ltd. from 2004 to 2008, and as Principal at Twenty-First Securities Corp. from 2002 to 2004. He earned his undergraduate degree from The University of Texas at Austin in 1999.
Prosight Management is a hedge fund managing discretionary assets totaling $658,651,000, as reported in their Form ADV dated March 2024, serving six clients. Their most recent 13F filing for Q1 2024 disclosed $359,452,762 in managed 13F securities, with a top 10 holdings concentration of 61.96%. Shattuck Labs, Inc. stands as the firm's largest holding, with 3,725,000 shares held.
